A Study To Evaluate the Feasibility of the Decentralized Clinical Trial in South Korea
- Conditions
- Functional Dyspepsia
- Interventions
- Behavioral: Dietary modificationDietary Supplement: Mastic gum
- Registration Number
- NCT06005805
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
The goal of this study is to evaluate the feasibility of a decentralized clinical trial in South Korea. The main questions it aims to answer are:
* Does decentralized elements feasible in Korea?
* Does Mastic gum alleviates symptoms and modifies stool microbiome in Korean patients with functional dyspepsia?
- Detailed Description
The trial aims to evaluate decentralized elements in South Korea, including clinical laboratory testing using local laboratories, medication adherence assessment using wearable devices, analysis of self-kit specimens, delivery and tracking of investigational medication, real-time remote interview of subjects and e-consent acquisition.
Mastic gum is registered with the Ministry of Food and Drug Safety in South Korea as a dietary supplement for gastric health, and the study aims to explore the effect on the gastrointestinal symptoms and composition of the stool microbiome.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Dietary modification Dietary modification Dietary modification (for 21 days) Mastic gum with dietary modification Dietary modification Mastic gum with dietary modification (for 21 days) Mastic gum with dietary modification Mastic gum Mastic gum with dietary modification (for 21 days)
- Primary Outcome Measures
Name Time Method Self-kit success rate up to 1 months Fraction of patients who utilized and delivered a self-test kit on the scheduled date
Adverse event management time up to 1 months In the event of an adverse event requiring medical attention, time from report to response
Specimen delivery time up to 1 months Time from collection at the local laboratory to delivery of specimen and reporting of results
- Secondary Outcome Measures
Name Time Method Self-evaluation questionnaire for dyspepsia (SEQ-DYSPEPSIA) score baseline, immediately after the intervention A self-evaluation questionnaire for dyspepsia score comprised 11 symptoms. Each symptom is measured on a 5-point scale for both frequency and intensity. The total score range from 22 to 110 and higher scores mean a worse outcome.
Gut Microbiome Index baseline, immediately after the intervention An index that combines microbial diversity, the proportion of pro-inflammatory microbes, the proportion of microbes that produce anti-inflammatory substances, and similarity to hunter-gatherers.
Trial Locations
- Locations (1)
Seoul National University Hospital Clinical Trial Center
🇰🇷Seoul, Korea, Republic of